000121079 001__ 121079
000121079 005__ 20240319080950.0
000121079 0247_ $$2doi$$a10.1007/s13555-022-00701-5
000121079 0248_ $$2sideral$$a131708
000121079 037__ $$aART-2022-131708
000121079 041__ $$aeng
000121079 100__ $$aKrajewski, Piotr K.
000121079 245__ $$aSelf-Reported Hidradenitis Suppurativa Severity: Is It Useful for Clinical Practice?
000121079 260__ $$c2022
000121079 5060_ $$aAccess copy available to the general public$$fUnrestricted
000121079 5203_ $$aIntroduction. Hidradenitis suppurativa (HS) is considered to be the most burdensome dermatosis, with a well-documented negative influence on quality of life (QoL). The patient’s perception of the disorder, assessed as the self-reported severity, has been used in other dermatoses but not in HS. The aim of this study was to evaluate the usefulness of self-reported HS severity in clinical practice.
Methods. The study was performed on a group of 130 Spanish HS patients. HS severity was assessed for all the subjects. Hurley staging and patient self-reported severity were used. Moreover, QoL impairment was evaluated using the Dermatology Life Quality Index (DLQI) and the Hidradenitis Suppurativa Quality of Life 24 (HSQoL-24) questionnaire.
Results. The severity of HS according to the Hurley staging was most commonly assessed as Hurley II (47.7%), indicating moderate disease, followed by severe disease (Hurley III, 26.9%) and mild disease (Hurley I, 25.4%). According to the patient self-reported HS severity, most of the patients reported having mild disease (76 patients, 58.5%), followed by moderate disease (31 patients, 23.8%). Only 23 patients (17.7%) assessed their disease as severe. Moreover, men reported mild disease significantly more frequently than women (70.9% and 49.3%, respectively; p = 0.014).
The self-reported HS severity correlated positively with the effect of the disease on patient QoL assessed with DLQI (r = 0.288, p < 0.001). Likewise, a strong positive correlation was found between self-reported HS severity and QoL impairment assessed with HSQoL-24 (r = 0.404, p = 0.001). No statistically significant correlation between Hurley severity stage and DLQI or HSQoL-24 was found. Moreover, there were significant differences in both DLQI and HSQoL-24 total score between different self-reported HS severities. This was not seen for any of the QoL instruments or for Hurley severity staging.
Conclusion. The results show that self-assessment severity may reflect patients’ subjective feelings more adequately than popular objective instruments, and there should be a place for its use in daily clinical practice.
000121079 540__ $$9info:eu-repo/semantics/openAccess$$aby-nc$$uhttp://creativecommons.org/licenses/by-nc/3.0/es/
000121079 590__ $$a3.4$$b2022
000121079 592__ $$a1.034$$b2022
000121079 591__ $$aDERMATOLOGY$$b20 / 70 = 0.286$$c2022$$dQ2$$eT1
000121079 593__ $$aDermatology$$c2022$$dQ1
000121079 594__ $$a4.9$$b2022
000121079 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000121079 700__ $$0(orcid)0000-0001-5632-0351$$aMarrón, Servando E.$$uUniversidad de Zaragoza
000121079 700__ $$0(orcid)0000-0003-1917-6906$$aTomas Aragones, Lucía
000121079 700__ $$0(orcid)0000-0001-8034-3617$$aGilaberte-Calzada, Yolanda$$uUniversidad de Zaragoza
000121079 700__ $$aSzepietowski, Jacek C.
000121079 7102_ $$11007$$2183$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cÁrea Dermatología
000121079 773__ $$g12 (2022), 899-909$$pDermatol. ther.$$tDermatology and therapy$$x2193-8210
000121079 8564_ $$s599630$$uhttps://zaguan.unizar.es/record/121079/files/texto_completo.pdf$$yVersión publicada
000121079 8564_ $$s2128699$$uhttps://zaguan.unizar.es/record/121079/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000121079 909CO $$ooai:zaguan.unizar.es:121079$$particulos$$pdriver
000121079 951__ $$a2024-03-18-13:00:53
000121079 980__ $$aARTICLE